Cryo-Cell International
CCEL
14 hedge funds and large institutions have $10.1M invested in Cryo-Cell International in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and closing their positions.
40% more funds holding
Funds holding: 10 → 14 (+4)
29% more capital invested
Capital invested by funds: $7.88M → $10.1M (+$2.25M)
2.89% more ownership
Funds ownership: 7.7% → 10.59% (+2.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$901K |
| 2 |
Millennium Management
New York
|
+$159K |
| 3 |
RP
Rowlandmiller & Partners
Atlanta,
Georgia
|
+$137K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$62.3K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$12.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
-$169K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$6.02K |
| 3 |
Morgan Stanley
New York
|
-$3.74K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.84K |
CCEL Hedge Fund Activity: Q4 2021 in Review
14 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q4 2021, worth a combined $10.1M — up 29% from $7.88M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CCEL positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $901K. The largest seller was ISZO Capital Management, cutting an estimated $169K.
- 14 institutional investors held Cryo-Cell International (CCEL) as of Q4 2021, up from 10 in Q3 2021.
- Funds reported $10.1M of Cryo-Cell International stock for Q4 2021, up 29% quarter-over-quarter.
- 4 funds opened new Cryo-Cell International positions in Q4 2021 and 0 closed out, a net change of +4 holders.
- The largest Cryo-Cell International buyer in Q4 2021 was Vanguard Group, an estimated $901K added.
- The largest Cryo-Cell International seller in Q4 2021 was ISZO Capital Management, an estimated $169K sold.
Based on aggregated 13F filings for Q4 2021.